TCR-enriched clonotype as well as acquisition method and application thereof
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HUNAN YUANPIN CELL TECH CO LTD
- Publication Date
- 2021-07-23
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biomedicine, in particular to a TCR-enriched clonotype and its acquisition method and application. Background technique
[0002] The outbreak of novel coronavirus (2019-novel coronavirus, 2019-nCoV) infection poses a serious threat to global public health. The disease caused by 2019-nCoV was officially named COVID-19 (coronavirus disease 2019) by the World Health Organization (WHO). COVID-19 is clinically manifested as pneumonia, fever, cough, muscle pain, fatigue, diarrhea and, in severe cases, death. The WHO report shows that 2019-nCoV has caused a worldwide pandemic. Vaccination is an effective means to prevent the spread of viral infection, but there is currently no new coronavirus vaccine (hereinafter referred to as the new crown vaccine). For the rapid spread of the COVID-19 virus in the public, the current treatment is still based on supportive care. Antiviral drugs, antibodies, and vaccines aga...